Global Pertussis Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Global Pertussis Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Table of Contents
1 Study Coverage
1.1 Pertussis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pertussis Vaccine Market Size Growth Rate by Type
1.2.2 Whole-cell vaccines
1.2.3 Acellular vaccines
1.3 Market by Application
1.3.1 Global Pertussis Vaccine Market Size Growth Rate by Application
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts
2.1.1 Global Pertussis Vaccine Revenue 2015-2026
2.1.2 Global Pertussis Vaccine Sales 2015-2026
2.2 Pertussis Vaccine Market Size by Region: 2020 Versus 2026
2.3 Pertussis Vaccine Sales by Region (2015-2026)
2.3.1 Global Pertussis Vaccine Sales by Region: 2015-2020
2.3.2 Global Pertussis Vaccine Sales Forecast by Region (2021-2026)
2.3.3 Global Pertussis Vaccine Sales Market Share by Region (2015-2026)
2.4 Pertussis Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pertussis Vaccine Revenue by Region: 2015-2020
2.4.2 Global Pertussis Vaccine Revenue Forecast by Region (2021-2026)
2.4.3 Global Pertussis Vaccine Revenue Market Share by Region (2015-2026)
3 Global Pertussis Vaccine by Manufacturers
3.1 Global Top Pertussis Vaccine Manufacturers by Sales
3.1.1 Global Pertussis Vaccine Sales by Manufacturer (2015-2020)
3.1.2 Global Pertussis Vaccine Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Pertussis Vaccine Manufacturers by Revenue
3.2.1 Global Pertussis Vaccine Revenue by Manufacturer (2015-2020)
3.2.2 Global Pertussis Vaccine Revenue Share by Manufacturer (2015-2020)
3.3 Global Pertussis Vaccine Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Pertussis Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Pertussis Vaccine Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Pertussis Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Pertussis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Pertussis Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Pertussis Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Corporation Information
4.1.2 Sanofi Pasteur Description, Business Overview
4.1.3 Sanofi Pasteur Pertussis Vaccine Products Offered
4.1.4 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Sanofi Pasteur Pertussis Vaccine Revenue by Product
4.1.6 Sanofi Pasteur Pertussis Vaccine Revenue by Application
4.1.7 Sanofi Pasteur Pertussis Vaccine Revenue by Geographic Area
4.1.8 Sanofi Pasteur Pertussis Vaccine Revenue by Sales Channel
4.1.9 Sanofi Pasteur Recent Development
4.2 GSK
4.2.1 GSK Corporation Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK Pertussis Vaccine Products Offered
4.2.4 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.2.5 GSK Pertussis Vaccine Revenue by Product
4.2.6 GSK Pertussis Vaccine Revenue by Application
4.2.7 GSK Pertussis Vaccine Revenue by Geographic Area
4.2.8 GSK Pertussis Vaccine Revenue by Sales Channel
4.2.9 GSK Recent Development
4.3 Mitsubishi Tanabe Pharma
4.3.1 Mitsubishi Tanabe Pharma Corporation Information
4.3.2 Mitsubishi Tanabe Pharma Description, Business Overview
4.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
4.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue by Product
4.3.6 Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue by Application
4.3.7 Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue by Geographic Area
4.3.8 Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue by Sales Channel
4.3.9 Mitsubishi Tanabe Pharma Recent Development
4.4 Wuhan Institute of Biological Products
4.4.1 Wuhan Institute of Biological Products Corporation Information
4.4.2 Wuhan Institute of Biological Products Description, Business Overview
4.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
4.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Wuhan Institute of Biological Products Pertussis Vaccine Revenue by Product
4.4.6 Wuhan Institute of Biological Products Pertussis Vaccine Revenue by Application
4.4.7 Wuhan Institute of Biological Products Pertussis Vaccine Revenue by Geographic Area
4.4.8 Wuhan Institute of Biological Products Pertussis Vaccine Revenue by Sales Channel
4.4.9 Wuhan Institute of Biological Products Recent Development
4.5 Walvax Biotechnology
4.5.1 Walvax Biotechnology Corporation Information
4.5.2 Walvax Biotechnology Description, Business Overview
4.5.3 Walvax Biotechnology Pertussis Vaccine Products Offered
4.5.4 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Walvax Biotechnology Pertussis Vaccine Revenue by Product
4.5.6 Walvax Biotechnology Pertussis Vaccine Revenue by Application
4.5.7 Walvax Biotechnology Pertussis Vaccine Revenue by Geographic Area
4.5.8 Walvax Biotechnology Pertussis Vaccine Revenue by Sales Channel
4.5.9 Walvax Biotechnology Recent Development
4.6 Minhai Biotechnology
4.6.1 Minhai Biotechnology Corporation Information
4.6.2 Minhai Biotechnology Description, Business Overview
4.6.3 Minhai Biotechnology Pertussis Vaccine Products Offered
4.6.4 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Minhai Biotechnology Pertussis Vaccine Revenue by Product
4.6.6 Minhai Biotechnology Pertussis Vaccine Revenue by Application
4.6.7 Minhai Biotechnology Pertussis Vaccine Revenue by Geographic Area
4.6.8 Minhai Biotechnology Recent Development
...
5 Breakdown Data by Type
5.1 Global Pertussis Vaccine Sales by Type (2015-2026)
5.1.1 Global Pertussis Vaccine Sales by Type (2015-2020)
5.1.2 Global Pertussis Vaccine Sales Forecast by Type (2021-2026)
5.1.3 Global Pertussis Vaccine Sales Market Share by Type (2015-2026)
5.2 Global Pertussis Vaccine Revenue Forecast by Type (2015-2026)
5.2.1 Global Pertussis Vaccine Revenue by Type (2015-2020)
5.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2021-2026)
5.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2015-2026)
5.3 Pertussis Vaccine Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Pertussis Vaccine Sales by Application (2015-2026)
6.1.1 Global Pertussis Vaccine Sales by Application (2015-2020)
6.1.2 Global Pertussis Vaccine Sales Forecast by Application (2021-2026)
6.1.3 Global Pertussis Vaccine Sales Market Share by Application (2015-2026)
6.2 Global Pertussis Vaccine Revenue Forecast by Application (2015-2026)
6.2.1 Global Pertussis Vaccine Revenue by Application (2015-2020)
6.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2021-2026)
6.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2015-2026)
6.3 Pertussis Vaccine Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Pertussis Vaccine Market Size YoY Growth 2015-2026
7.2 North America Pertussis Vaccine Market Facts & Figures by Country
7.2.1 North America Pertussis Vaccine Sales by Country (2015-2026)
7.2.2 North America Pertussis Vaccine Revenue by Country (2015-2026)
7.3 North America Pertussis Vaccine Sales by Type
7.4 North America Pertussis Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Pertussis Vaccine Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Pertussis Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Pertussis Vaccine Sales by Region (2015-2026)
8.2.2 Asia-Pacific Pertussis Vaccine Revenue by Region (2015-2026)
8.3 Asia-Pacific Pertussis Vaccine Sales by Type
8.4 Asia-Pacific Pertussis Vaccine Sales by Application
9 Europe
9.1 Europe Pertussis Vaccine Market Size YoY Growth 2015-2026
9.2 Europe Pertussis Vaccine Market Facts & Figures by Country
9.2.1 Europe Pertussis Vaccine Sales by Country (2015-2026)
9.2.2 Europe Pertussis Vaccine Revenue by Country (2015-2026)
9.3 Europe Pertussis Vaccine Sales by Type
9.4 Europe Pertussis Vaccine Sales by Application
10 Latin America
10.1 Latin America Pertussis Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Pertussis Vaccine Market Facts & Figures by Country
10.2.1 Latin America Pertussis Vaccine Sales by Country (2015-2026)
10.2.2 Latin America Pertussis Vaccine Revenue by Country (2015-2026)
10.3 Latin America Pertussis Vaccine Sales by Type
10.4 Latin America Pertussis Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Pertussis Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pertussis Vaccine Sales by Country (2015-2026)
11.2.2 Middle East and Africa Pertussis Vaccine Revenue by Country (2015-2026)
11.3 Middle East and Africa Pertussis Vaccine Sales by Type
11.4 Middle East and Africa Pertussis Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Pertussis Vaccine Supply Chain Analysis
12.2 Pertussis Vaccine Key Raw Materials and Upstream Suppliers
12.3 Pertussis Vaccine Clients Analysis
12.4 Pertussis Vaccine Sales Channel and Sales Model Analysis
12.4.1 Pertussis Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Pertussis Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Pertussis Vaccine Distributors
13 Market Dynamics
13.1 Pertussis Vaccine Market Drivers
13.2 Pertussis Vaccine Market Opportunities
13.3 Pertussis Vaccine Market Challenges
13.4 Pertussis Vaccine Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of Whole-cell vaccines
Table 3. Major Manufacturers of Acellular vaccines
Table 4. Global Pertussis Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Pertussis Vaccine Market Size by Region (US$ Million): 2020 VS 2026
Table 6. Global Pertussis Vaccine Sales by Region (2015-2020) & (K Doses)
Table 7. Global Pertussis Vaccine Sales Forecast by Region (2021-2026) & (K Doses)
Table 8. Global Pertussis Vaccine Revenue by Region (2015-2020) & (US$ Million)
Table 9. Global Pertussis Vaccine Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 10. Global Pertussis Vaccine Sales by Manufacturer (2015-2020) & (K Doses)
Table 11. Global Pertussis Vaccine Sales Share by Manufacturer (2015-2020)
Table 12. Pertussis Vaccine Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 13. Pertussis Vaccine Revenue Share by Manufacturer (2015-2020)
Table 14. Key Manufacturers Pertussis Vaccine Price (2015-2020) & (USD/Doses)
Table 15. Ranking of Global Top Pertussis Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 16. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 17. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2019)
Table 18. Pertussis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Pertussis Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Pertussis Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Sanofi Pasteur Corporation Information
Table 23. Sanofi Pasteur Description and Business Overview
Table 24. Sanofi Pasteur Pertussis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 25. Sanofi Pasteur Pertussis Vaccine Product
Table 26. Sanofi Pasteur Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
Table 27. Sanofi Pasteur Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
Table 28. Sanofi Pasteur Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 29. Sanofi Pasteur Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 30. Sanofi Pasteur Recent Development
Table 31. GSK Corporation Information
Table 32. GSK Description and Business Overview
Table 33. GSK Pertussis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 34. GSK Pertussis Vaccine Product
Table 35. GSK Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
Table 36. GSK Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
Table 37. GSK Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 38. GSK Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 39. GSK Recent Development
Table 40. Mitsubishi Tanabe Pharma Corporation Information
Table 41. Mitsubishi Tanabe Pharma Description and Business Overview
Table 42. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 43. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
Table 44. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
Table 45. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
Table 46. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 47. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 48. Mitsubishi Tanabe Pharma Recent Development
Table 49. Wuhan Institute of Biological Products Corporation Information
Table 50. Wuhan Institute of Biological Products Description and Business Overview
Table 51. Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 52. Wuhan Institute of Biological Products Pertussis Vaccine Product
Table 53. Wuhan Institute of Biological Products Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
Table 54. Wuhan Institute of Biological Products Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
Table 55. Wuhan Institute of Biological Products Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 56. Wuhan Institute of Biological Products Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 57. Wuhan Institute of Biological Products Recent Development
Table 58. Walvax Biotechnology Corporation Information
Table 59. Walvax Biotechnology Description and Business Overview
Table 60. Walvax Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 61. Walvax Biotechnology Pertussis Vaccine Product
Table 62. Walvax Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
Table 63. Walvax Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
Table 64. Walvax Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 65. Walvax Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 66. Walvax Biotechnology Recent Development
Table 67. Minhai Biotechnology Corporation Information
Table 68. Minhai Biotechnology Description and Business Overview
Table 69. Minhai Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 70. Minhai Biotechnology Pertussis Vaccine Product
Table 71. Minhai Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
Table 72. Minhai Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
Table 73. Minhai Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 74. Minhai Biotechnology Recent Development
Table 75. Global Pertussis Vaccine Sales by Type (2015-2020) & (K Doses)
Table 76. Global Pertussis Vaccine Sales Forecast by Type (2021-2026) & (K Doses)
Table 77. Global Pertussis Vaccine Revenue by Type (2015-2020) & (US$ Million)
Table 78. Global Pertussis Vaccine Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 79. Global Pertussis Vaccine Sales by Application (2015-2020) & (K Doses)
Table 80. Global Pertussis Vaccine Sales Forecast by Application (2021-2026) & (K Doses)
Table 81. Global Pertussis Vaccine Revenue by Application (2015-2020) & (US$ Million)
Table 82. Global Pertussis Vaccine Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 83. North America Pertussis Vaccine Sales by Country (2015-2020) & (K Doses)
Table 84. North America Pertussis Vaccine Sales by Country (2021-2026) & (K Doses)
Table 85. North America Pertussis Vaccine Revenue by Country (2015-2020) & (US$ Million)
Table 86. North America Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 87. North America Pertussis Vaccine Sales by Type (2015-2020) & (K Doses)
Table 88. North America Pertussis Vaccine Sales by Application (2015-2020) & (K Doses)
Table 89. Asia-Pacific Pertussis Vaccine Sales by Region (2015-2020) & (K Doses)
Table 90. Asia-Pacific Pertussis Vaccine Sales by Region (2021-2026) & (K Doses)
Table 91. Asia-Pacific Pertussis Vaccine Revenue by Region (2015-2026) & (US$ Million)
Table 92. Asia-Pacific Pertussis Vaccine Revenue by Region (2021-2026) & (US$ Million)
Table 93. Asia-Pacific Pertussis Vaccine Sales by Type (2015-2020) & (K Doses)
Table 94. Asia-Pacific Pertussis Vaccine Sales by Application (2015-2020) & (K Doses)
Table 95. Europe Pertussis Vaccine Sales by Country (2015-2020) & (K Doses)
Table 96. Europe Pertussis Vaccine Sales by Country (2021-2026) & (K Doses)
Table 97. Europe Pertussis Vaccine Revenue by Country (2015-2020) & (US$ Million)
Table 98. Europe Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 99. Europe Pertussis Vaccine Sales by Type (2015-2020) & (K Doses)
Table 100. Europe Pertussis Vaccine Sales by Application (2015-2020) & (K Doses)
Table 101. Latin America Pertussis Vaccine Sales by Country (2015-2020) & (K Doses)
Table 102. Latin America Pertussis Vaccine Sales by Country (2021-2026) & (K Doses)
Table 103. Latin America Pertussis Vaccine Revenue by Country (2015-2020) & (US$ Million)
Table 104. Latin America Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 105. Latin America Pertussis Vaccine Sales by Type (2015-2020) & (K Doses)
Table 106. Latin America Pertussis Vaccine Sales by Application (2015-2020) & (K Doses)
Table 107. Middle East and Africa Pertussis Vaccine Sales by Country (2015-2020) & (K Doses)
Table 108. Middle East and Africa Pertussis Vaccine Sales by Country (2021-2026) & (K Doses)
Table 109. Middle East and Africa Pertussis Vaccine Revenue by Country (2015-2020) & (US$ Million)
Table 110. Middle East and Africa Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 111. Middle East and Africa Pertussis Vaccine Sales by Type (2015-2020) & (K Doses)
Table 112. Middle East and Africa Pertussis Vaccine Sales by Application (2015-2020) & (K Doses)
Table 113. Pertussis Vaccine Key Raw Materials, Industry Status and Trend
Table 114. Pertussis Vaccine Key Raw Materials and Upstream Suppliers
Table 115. Pertussis Vaccine Clients Status and Trend
Table 116. Pertussis Vaccine Typical Clients
Table 117. Pertussis Vaccine Distributors
Table 118. Key Drivers: Impact Analysis (2021-2026)
Table 119. Pertussis Vaccine Market Drivers
Table 120. Pertussis Vaccine Market Opportunities
Table 121. Pertussis Vaccine Market Challenges
Table 122. Pertussis Vaccine Market Restraints
Table 123. Pertussis Vaccine Porter's Five Forces Analysis
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Whole-cell vaccines Product Picture
Figure 4. Acellular vaccines Product Picture
Figure 5. Global Pertussis Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Children Examples
Figure 7. Adults Examples
Figure 8. Pertussis Vaccine Report Years Considered
Figure 9. Global Pertussis Vaccine Market Size, (US$ Million), 2015 VS 2020 VS 2026
Figure 10. Global Pertussis Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Pertussis Vaccine Sales 2015-2026 (K Units)
Figure 12. Global Pertussis Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Pertussis Vaccine Sales Market Share Forecast by Region (2015-2026)
Figure 14. Global Pertussis Vaccine Revenue Market Share by Region (2015-2026)
Figure 15. Global Pertussis Vaccine Sales Share by Manufacturer in 2019
Figure 16. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Pertussis Vaccine Sales Market Share Forecast by Type (2015-2026)
Figure 18. Global Pertussis Vaccine Revenue Market Share Forecast by Type (2015-2026)
Figure 19. Pertussis Vaccine Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)
Figure 20. Global Pertussis Vaccine Sales Market Share Forecast by Application (2015-2026)
Figure 21. Global Pertussis Vaccine Revenue Market Share Forecast by Application (2015-2026)
Figure 22. Pertussis Vaccine Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)
Figure 23. North America Pertussis Vaccine Revenue 2015-2026 (US$ Million)
Figure 24. North America Pertussis Vaccine Sales Market Share by Type (2015-2020)
Figure 25. North America Pertussis Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Asia-Pacific Pertussis Vaccine Revenue 2015-2026 (US$ Million)
Figure 27. Asia-Pacific Pertussis Vaccine Sales Market Share by Region (2015-2026)
Figure 28. Asia-Pacific Pertussis Vaccine Revenue Market Share by Region (2015-2026)
Figure 29. Asia-Pacific Pertussis Vaccine Sales Market Share by Type (2015-2020)
Figure 30. Asia-Pacific Pertussis Vaccine Sales Market Share by Application (2015-2020)
Figure 31. Europe Pertussis Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. Europe Pertussis Vaccine Sales Market Share by Country (2015-2026)
Figure 33. Europe Pertussis Vaccine Revenue Market Share by Country (2015-2026)
Figure 34. Europe Pertussis Vaccine Sales Market Share by Type (2015-2020)
Figure 35. Europe Pertussis Vaccine Sales Market Share by Application (2015-2020)
Figure 36. Latin America Pertussis Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 37. Latin America Pertussis Vaccine Sales Market Share by Country (2015-2026)
Figure 38. Latin America Pertussis Vaccine Revenue Market Share by Country (2015-2020)
Figure 39. Latin America Pertussis Vaccine Sales Market Share by Type (2015-2020)
Figure 40. Latin America Pertussis Vaccine Sales Market Share by Application (2015-2020)
Figure 41. Middle East and Africa Pertussis Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 42. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2015-2026)
Figure 43. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2015-2026)
Figure 44. Middle East and Africa Pertussis Vaccine Sales Market Share by Type (2015-2020)
Figure 45. Middle East and Africa Pertussis Vaccine Sales Market Share by Application (2015-2020)
Figure 46. Pertussis Vaccine Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Pertussis Vaccine Raw Materials by Region in 2019
Figure 48. Pertussis Vaccine Distribution Channels
Figure 49. Global Pertussis Vaccine Percentage 2015-2026: Indirect Sales VS Direct Sales
Figure 50. Global Pertussis Vaccine Percentage 2015-2026: Online Sales VS Offline Sales
Figure 51. Porter's Five Forces Analysis
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs